Polyethylenimine-mediated transfection of human monocytes with the IFN-γ gene: An approach for cancer adoptive immunotherapy

Gene Therapy

Volumn 5, Issue 11, 1998, Pages 1508-1516

  Ringenbach, L ^a   Bohbot, A ^a   Tiberghien, P ^b   Oberling, F ^a   Feugeas, O ^a  

^a Institut d'Hématologie   (France)

^b Etablissement de Transfus Sang   (France)

Author keywords

Adoptive immunotherapy; Cationic vector; Human monocytes; IFN

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; GENE TRANSFER; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0031772474     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300756     Document Type: Article

References (49)

1. Rinehart JJ et al. Human monocyte-induced tumor cell cytotoxicity. Blood 1978; 52: 211-220.
2. Mantovani A, Polentarutt N, Perri G. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumor. J Natl Cancer Inst 1980, 64: 1307-1315.
3. Zlabinger GJ, Mannhalter JW, Eibl MM. Cord blood macrophages present bacterial antigen (Escherichia coli) to paternal T cells. Clin Immunol Immunopathol 1983; 28: 405-412.
4. Becker S et al. Interleukin-1 production and antigen presentation by normal human peritoneal macrophages. Cell Immunol 1986; 98: 467-476.
5. Auron PE et al. Nucleotide sequence of human monocyte interleukin-1 precurseur cDNA. Proc Natl Acad Sci USA 1984; 81: 7907-7911.
6. Carswell EA et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670.
7. Sehgal PB et al. Human beta 2 interferon and B cell differentiation factor BSF-2 are identical. Science 1987; 235: 731-732.
8. Munn DH, Cheung NK. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibodymediated antitumor cvtotoxicity not detected by isotope release assays J Exp Med 1989; 170: 511-526.
9. Drysdale BE, Agarwal S, Shin HS. Macrophage-mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog Allergy 1988; 40: 111-161.
10. Fidler IJ, Kleinerman ES. Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions. J Clin Oncol 1984; 2: 937-943.
11. Itoh K, Platsoucas CD, Balch CM. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells. Cell Immunol 1987; 108: 495-500.
12. Fidler IJ et al. Eradication of spontaneous metastases and acti- vation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 1981; 78: 1680-1684.
13. Kleinerman ES, Erickson KL, Schroit AJ. Activation of rumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide. Cancer Res 1983; 43: 2010-2014,
14. Weinberg JB, Chapman HA, Hibbs JB. Characterisation of effects of endotoxin on macrophage tumor cell killing. J Immunol 1978; 121: 72-80.
15. Jett JR, Mantovani A, Herberman RB. Augmentation of human monocyte-mediated cytolysis by interferon. Cell Immunol 1980; 54: 425-434.
16. Le J et al. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. J Immunol 1983; 131: 2821-2826.
17. Young HA, Hardy KJ. Role of interferon-γ in immune cell regulation. J Leukoc Biol 1995; 58: 373-381.
18. Poste G, Kirsh R. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages. Cancer Res 1979; 39: 2582-2590.
19. Faradji A et al. Phase I trial of intravenous infusion of ex vivo activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol Immunother 1991; 33: 319-326.
20. Fidler IJ. Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res 1974; 34: 1074-1078.
21. Stevenson HC, Foon KA, Sugarbaker PH. Ex vivo activated monocytes and adoptive immunotherapy trials in colon cancer patients. Prog Clin Biol Res 1986; 211: 75-82.
22. Behr JP et al. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 1989; 86: 6982-6986.
23. Feugeas O et al. The monocyte: another cell for gene transfer in adoptive immunotherapy of cancer. Cancer Gene Ther 1993; 1:14.
24. Labat-Moleur F et al. An electron microscopy study into the mecanism of gene transfer with lipopolyamines. Gene Therapy 1996; 3: 1010-1017.
25. Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
26. Boussif O, Zanta MA, Behr JP. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Therapy 1996; 3: 1074-1080.
27. Harms JS, Splitter GA. Interferon-γ inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 1995; 6: 1291-1297.
28. Haddada H et a!. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun 1993; 195: 1174-1183.
29. Ahuja SS et al. Autocrine activation of hemopoietic progenitordenved myelo-monocytic cells by IFN-γ transfer. J Immunol 1996; 156: 4345-4353.
30. Ramesh N et al. High level expression from a cytomegalovirus promoter in macrophage cells. Hum Gene Ther 1995; 6: 1323-1327.
31. Watson RB et al.γ-IFN receptor expression in haemic malignancies. Leukemia Res 1990; 14: 657-660.
32. Bohbot A et al. U937 cell line, impact of CSFs, IL-6 and IFNgamma on the differentiation and the Leu-CAM proteins expression. Exp Hematol 1993; 21: 564-572.
33. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659-667.
34. Kruys V et al. Translation blockade imposed by cytokinederived AU-rich sequences. Science 1989; 245: 852-855.
35. Rajagopalan LE et al. Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues. Blood 1995; 86: 2551-2558.
36. Eischen A et al. Long-term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J Immunol Meth 1991; 143: 209-221.
37. Kiener PA et a). Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J Exp Med 1997; 185: 1511-1516.
38. Kitagawa S et al. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of Superoxide and erythrophagocytosis, but no direct triggering of Superoxide release. Exp Hematol 1996; 24: 559-567.
39. Smith PD et al. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J Immunol 1990; 144: 3829-3834.
40. Grabstein KH et al. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986; 232: 506-008.
41. Kleinerman ES et al. Effect of recombinant granulocyte-macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res 1988; 48: 2604-2609.
42. Cannistra SA et al. Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 1988; 71: 672-676.
43. Hart PH et al. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-γ. Increased TNF-α but not IL-1 activity. J Immunol 1988; 141: 1516-1521.
44. Kornbluth RS, Gregory SA, Edginton TS. Initial characterization of a lymphokine pathway for the immunologie induction of tumor necrosis factor-alpha release from human peripheral blood monoimdear cells. J Immunol 1988; 141: 2006-2015.
45. Wiltschke C et al. Influence of in vivo administration of GMCSF and G-CSF on monocyte cytotoxicity. Exp Hematol 1995; 23: 402-106.
46. Finbloom DS. Regulation of cell-surface receptors for human interferon-gamma on the human histiocytic Lymphoma cell line U937. Biochem J 1991; 274: 775-780.
47. Finbloom DS et al. Culture of human monocytes with granulocyte-macrophage colony-stimulating factor results in enhancement of IFN-γ receptor but suppression of IFN-γ-induced expression of the gene IP-10. J Immunol 1993; 150: 2383-2390.
48. Munn DH, Cheung NV. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor. Cancer Immunol Immunother 1995; 41: 46-52.
49. Devos R et al. Molecular cloning of human immune Interferon cDNA and its expression in eukaryotic cells. Nucleic Acids Res 1982; 10: 2487-2500.